Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02945943 · ClinicalTrials.gov registry record · NA
Effects of Mobilization in Conjunction With Therapeutic Exercise in Participants With a History of Ankle Sprain
A NA study, sponsored by Shenandoah University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02945943: Completed NA study, sponsored by Shenandoah University.
NCT02945943 is a NA study that has completed, run by Shenandoah University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02945943, a NA study, has completed, sponsored by Shenandoah University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Our purpose was to examine the combined effects of thrust mobilization of the proximal and distal ankle joints in conjunction with a six-week rehabilitation program on ankle function in subjects reporting chronic ankle instability (CAI).
Primary Outcome
The participant began the test on either side of a demarcated 5-meter distance. While standing on the involved ankle, the participant was instructed to "hop on one foot, as fast as you can," twice around the figure 8. Two trials were performed with the fastest time being recorded.
Interventions
- OTHER Exercise Protocol
- OTHER High Velocity Low Amplitude mobilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-10 |
| Phase | NA |
What the finished NCT02945943 record still lists
NCT02945943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Exercise Protocol is the first listed.
NCT02945943 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02945943 about?
NCT02945943 is a clinical study titled "Effects of Mobilization in Conjunction With Therapeutic Exercise in Participants With a History of Ankle Sprain". Our purpose was to examine the combined effects of thrust mobilization of the proximal and distal ankle joints in conjunction with a six-week rehabilitation program on ankle function in subjects reporting chronic ankle instability (CAI).
What is the current status of trial NCT02945943?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2012-02. Estimated completion is 2013-10.
What interventions are being tested in trial NCT02945943?
The interventions under investigation include: Exercise Protocol (OTHER), High Velocity Low Amplitude mobilization (OTHER).
Who is sponsoring clinical trial NCT02945943?
This trial is sponsored by Shenandoah University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02945943's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia